Oncolytics Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.

About ONCY

Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. 

CEO
Jared Kelly
CEOJared Kelly
Employees
28
Employees28
Headquarters
Calgary, Alberta
HeadquartersCalgary, Alberta
Founded
1998
Founded1998
Employees
28
Employees28

ONCY Key Statistics

Market cap
104.79M
Market cap104.79M
Price-Earnings ratio
-3.98
Price-Earnings ratio-3.98
Dividend yield
Dividend yield
Average volume
607.09K
Average volume607.09K
High today
$1.15
High today$1.15
Low today
$1.01
Low today$1.01
Open price
$1.08
Open price$1.08
Volume
611.46K
Volume611.46K
52 Week high
$1.53
52 Week high$1.53
52 Week low
$0.3258
52 Week low$0.3258

ONCY News

TipRanks 1d
Oncolytics Biotech to Participate in September Investor Conferences

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own ONCY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.